Dopolnitel'nyy priem folievoy kisloty i beremennost': profilaktika defektov nervnoy trubki i ne tol'ko


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Folate (vitamin B9) is an essential nutrient that is required for DNA replication and as a substrate for a range of enzymatic reactions involved in amino acid synthesis and vitamin metabolism. Demands for folate increase during pregnancy because it is also required for growth and development of the fetus. Folate deficiency has been associated with abnormalities in both mothers (anemia, peripheral neuropathy) and fetuses (congenital abnormalities). This article reviews the metabolism of folic acid, the appropriate use of folic acid supplementation in pregnancy, and the potential benefits of folic acid, as well as the possible supplementation of L-methylfolate for the prevention of pregnancy-related complications other than neural tube defects.

Негізгі сөздер

Толық мәтін

Рұқсат жабық

Авторлар туралы

Dzheyms Grinberg

Steysi Bell

- Yong Guan

- Yan-khong Yu

Әдебиет тізімі

  1. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338:131-37.
  2. Rieder MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatol 1994;21:483-503.
  3. Pitkin RM. Folate and neural tube defects. Am J Clin Nutr. 2007;85:285S-88S.
  4. De Wals P, Tairou F, Van Allen Mi, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357:135-42.
  5. Pietrzik K, Bailey L, Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2010; 48:535-48.
  6. Bodnar LM, Himes KP, Venkataramanan R, et al. Maternal serum folate species in early pregnancy and risk of preterm birth. Am J Clin Nutr 2010;92:864-71.
  7. Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr. 2001;21:255-82.
  8. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev 2008;13:216-26.
  9. Ulrich CM, Kampman E, Bigler J, et al. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol Biomarkers Prev 2000;9:427-33.
  10. Weisberg iS, Jacques PF, Selhub J, et al. The 1298 A ->C polymorphism in methylenetet-rahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis. 2001;156:409-15.
  11. US Food and Drug Administration. Food Standards. Amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781-96.
  12. Bureau of Food Regulatory. international and interagency Affairs, Health C. Regulatory impact analysis statement. Canada Gazette Part ii. 1998;132:3029-33.
  13. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.
  14. Dietrich M, Brown CJ, Block G. The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult nonsupplement users in the United States. J Am Coll Nutr 2005;24:266-74.
  15. Honein MA, Paulozzi LJ, Mathews TJ, et al. impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-86.
  16. Williams LJ, Mai CT, Edmonds LD, et al. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 2002;66:33-39.
  17. Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004;53:362-65.
  18. Institute of Medicine, Food and Nutrition Board. Dietary Reference intakes: Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 1998.
  19. Wilson RD, Johnson JA, Wyatt P, et al; Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada and The Motherrisk Program. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2007;29:1003-26.
  20. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 2006;84:156-61.
  21. Pritchard JA, Adams RH. Erythrocyte production and destruction during pregnancy. Am J Obstet Gynecol 1960;79:750-57.
  22. Cunningham F, Leveno K, Bloom S, et al. Hematological disorders. in: Williams Obstetrics, 23rd ed. New York: McGraw-Hill, 2009.
  23. Koury MJ, Ponka P. New insights into erythropoiesis:the role of folate, vitamin B12 and iron. Annu Rev Nutr 2004;24:105-31.
  24. Bentley S, Hermes A, Phillips D, et al. Comparative effectiveness of a prenatal medical food to prenatal vitamins on hemoglobin levels and adverse outcomes: a retrospective analysis. Clin Therapeut 2011;33:204-10.
  25. Behrman RE, Butler AS, eds. Preterm Birth: Causes, Consequences, and Prevention. institute of Medicine. Washington, DC: The National Academies Press, 2007.
  26. Lockwood CJ, Kuczynski E. Risk stratification and pathological mechanisms in preterm delivery. Paediatr Perinat Epidemiol 2001;15:78-89.
  27. Fisk NM, Atun R. Market failure and the poverty of new drugs in maternal health. PLoS Med. 2008;5:e22.
  28. Malinow MR, Rajkovic A, Duell PB, et al. The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocysteine in fetal metabolism. Am J Obstet Gynecol 1998;178:228-33.
  29. Tchernia G, Blot i, Rey A, et al. Maternal folate status, birthweight and gestational age. Dev Pharmacol Ther 1982;4(suppl): 58-65.
  30. Keen CL, Clegg MS, Hanna LA, et al. The plausibility of micronutrient deficiencies being a significant contributing factor to the occurrence of pregnancy complications. J Nutr 2003;133(5 suppl 2):1597S-605S.
  31. Neggers Y, Goldenberg RL. Some thoughts on body mass index, micronutrient intakes and pregnancy outcome. J Nutr 2003;133(5 suppl 2):1737S-40S.
  32. Allen LH. Multiple micronutrients in pregnancy and lactation: an overview. Am J Clin Nutr. 2005;81:1206S-12S.
  33. Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev 2006;(4):CD004905.
  34. Czeizel AE, Puho EH, Langmar Z, et al. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: apopulation-based study. Eur J Obstet Gynecol Reprod Biol 2010;148:135-40.
  35. Muggli EE, Halliday JL. Folic acid and risk of twinning: a systematic review of the recent literature, July 1994 to July 2006. Med J Aust 2007;186:243-48.
  36. Bukowski R, Malone FD, Porter FT, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med 2009;6:e1000061.
  37. Courtemanche C, Elson-Schwab i, Mashiyama ST, et al. Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. J immunol 2004; 173:3186-92.
  38. Christian P, Jiang T, Khatry SK, et al. Antenatal supplementation with micronutrients and biochemical indicators of status and sub-clinical infection in rural Nepal. Am J Clin Nutr 2006;83:788-94.
  39. Dhur A, Galan P, Hercberg S. Folate status and the immune system. Prog Food Nutr Sci 1991;15:43-60.
  40. Johnson WG, Scholl TO, Spychala JR, et al. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery. Am J Clin Nutr 2005; 81:664-68.
  41. Engel SM, Olshan AF, Siega-Riz AM, et al. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am J Obstet Gynecol 2006; 195:1231.e1-e11.
  42. Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 2003; 121A:95-101.
  43. Bailey LB, Berry RJ. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am J Clin Nutr 2005;81: 1213S-17S.
  44. Huhta JC, Linask K, Bailey L. Recent advances in the prevention of congenital heart disease. Curr Opin Pediatr 2006;18:484-89.
  45. ionescu-ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 2009;338;b1673.
  46. Huhta JC, Hernandez-Robles JA. Homocysteine, folate, and congenital heart defects. Fetal Pediatr Pathol 2005; 24:71-79.
  47. Wen SW, Chen XK, Rodger M, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008; 198:45.e1-e7.
  48. Ray JG, Laskin C. Folic acid and homocyst(e) ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-29.
  49. Wen SW, Zhou J, Yang Q, et al. Maternal exposure to folic acid antagonists and placenta mediated adverse pregnancy outcomes. CMAJ 2008;179:1263-68.
  50. Yang J, Xie RH, Krewski D, et al. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. int J infect Dis 2011;15:e336-e341.
  51. Williams PJ, Bulmer JN, innes BA, Broughton Pipkin F. Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy. Biol Reprod 2011;84:1148-53.
  52. Morris MS, Jacques PF, Rosenberg iH, Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr 2010;91:1733-44.
  53. Frankenburg FR. Folate supplementation: is it safe and effective? J Clin Psychiatry 2009;70:767;author reply 767-69.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2012

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>